Literature DB >> 15686631

Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.

Chanan Rubin1, Gal Gur, Yosef Yarden.   

Abstract

Intracellular signals mediated by the family of receptor tyrosine kinases play pivotal roles in morphogenesis, cell fate determination and pathogenesis. Precise control of signal amplitude and duration is critical for the fidelity and robustness of these processes. Activation of receptor tyrosine kinases by their cognate growth factors not only leads to propagation of the signal through various biochemical cascades, but also sets in motion multiple attenuation mechanisms that ultimately terminate the active state. Early attenuators pre-exist prior to receptor activation and they act to limit signal propagation. Subsequently, late attenuators, such as Lrig and Sprouty, are transcriptionally induced and further act to dampen the signal. Central to the process of signaling attenuation is the role of the E3 ubiquitin ligase c-Cbl. While Cbl-mediated processes of receptor ubiquitylation and endocytosis are relatively well understood, the links of Cbl to other negative regulators are just now beginning to be appreciated. Here we review some emerging interfaces between Cbl and the transcriptionally induced negative regulators Lrig and Sprouty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686631     DOI: 10.1038/sj.cr.7290268

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  26 in total

Review 1.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

2.  LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.

Authors:  James S Meabon; Rian De Laat; Katsuaki Ieguchi; Jesse C Wiley; Mark P Hudson; Mark Bothwell
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

3.  Ubiquitylation and developmental regulation of invariant surface protein expression in trypanosomes.

Authors:  Ka Fai Leung; Fay S Riley; Mark Carrington; Mark C Field
Journal:  Eukaryot Cell       Date:  2011-05-13

4.  LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling.

Authors:  Longchuan Bai; Donna McEachern; Chao-Yie Yang; Jianfeng Lu; Haiying Sun; Shaomeng Wang
Journal:  Cancer Res       Date:  2012-01-12       Impact factor: 12.701

Review 5.  Dissection of genetic pathways in C. elegans.

Authors:  Zheng Wang; David R Sherwood
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

6.  Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.

Authors:  Zee Upton; Hilary J Wallace; Gary K Shooter; Derek R van Lonkhuyzen; Sim Yeoh-Ellerton; Erin A Rayment; Jacqui M Fleming; Daniel Broszczak; Douglas Queen; R Gary Sibbald; David I Leavesley; Michael C Stacey
Journal:  Int Wound J       Date:  2011-10       Impact factor: 3.315

7.  Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.

Authors:  Aleksandra Glogowska; Jörg Stetefeld; Ekkehard Weber; Saeid Ghavami; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

Review 8.  Intermolecular interactions of Sprouty proteins and their implications in development and disease.

Authors:  Francis Edwin; Kimberly Anderson; Chunyi Ying; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

Review 9.  Endocytosis and intracellular trafficking of ErbBs.

Authors:  Alexander Sorkin; Lai Kuan Goh
Journal:  Exp Cell Res       Date:  2008-08-28       Impact factor: 3.905

10.  Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor.

Authors:  Ning Sheng Liu; Li Shen Loo; Eva Loh; Li-Fong Seet; Wanjin Hong
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.